Publication:
Electrochemical Monitoring of the Interaction of Cisplatin with Cystine and Ascorbic Acid

dc.authorscopusid55774433600
dc.authorscopusid6603524165
dc.authorscopusid7004387719
dc.contributor.authorÇakir, S.
dc.contributor.authorBi̇Çer, E.
dc.contributor.authorÇakir, O.
dc.date.accessioned2020-06-21T15:49:48Z
dc.date.available2020-06-21T15:49:48Z
dc.date.issued2000
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Çakir] Semiha, Department of Chemistry, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bi̇Çer] Ender, Department of Chemistry, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Çakir] Osman, Department of Chemistry, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractThe interaction of cisplatin with cystine (RSSR) and ascorbic acid (AA) has been investigated in aqueous solution at physiological pH, using drug concentration of 0.835 x 10-6 M to 46.76 x 10-6 M with RSSR concentration of 6.5 x 10-5 M by voltammetric techniques. Voltammetric results show that at low drug concentration (< 0.835 x 10-6 M), the interaction between cisplatin and RSSR occurs slightly, while at higher drug concentrations (≥ 0.835 x 10-6 M), cisplatin binds to RSSR and gives an unseparated-reduction peak at -0.610 V. Based on the voltammetric behaviour of RSSR, it has been suggested that binding of cisplatin to RSSR occurs mainly at the disulphide bond. It has been shown that the interaction of cisplatin with RSSR in the presence of AA is very rapid with regards to the interaction without AA, and a new peak, probably corresponding to the interaction of cisplatin with RSSR and AA is appeared at -0.970 V. The fractional coefficient for the binding of cisplatin to RSSR with or without AA was calculated to be 0.031 and 0.055, respectively. (C) 2000 Elsevier Science S.A.en_US
dc.identifier.doi10.1016/S1388-2481(00)00086-2
dc.identifier.endpage590en_US
dc.identifier.issn1388-2481
dc.identifier.issue8en_US
dc.identifier.scopus2-s2.0-0033826137
dc.identifier.scopusqualityQ1
dc.identifier.startpage586en_US
dc.identifier.urihttps://doi.org/10.1016/S1388-2481(00)00086-2
dc.identifier.volume2en_US
dc.identifier.wosWOS:000088602000007
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofElectrochemistry Communicationsen_US
dc.relation.journalElectrochemistry Communicationsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnti-Cancer Drugen_US
dc.subjectAscorbic Aciden_US
dc.subjectCisplatinen_US
dc.subjectCystineen_US
dc.subjectMixed Ligand Complexen_US
dc.subjectVoltammetryen_US
dc.titleElectrochemical Monitoring of the Interaction of Cisplatin with Cystine and Ascorbic Aciden_US
dc.typeArticleen_US
dspace.entity.typePublication

Files